ACCOLADE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.89 USD | -14.15% |
|
-13.58% | -34.30% |
| 26/04 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
| 25/04 | Transcript : Accolade, Inc., Q4 2024 Earnings Call, Apr 25, 2024 |
Chart calendar Accolade, Inc.
ecfbb9349dca94e1a.sHRUIGZDT_42Jk82f4Ews5ZfSLboDd3oekV2IZcR_EQ.nRgndTcqN7lFQAoONbhn8NMoEIHaWK6yJRw3d9loqQHyJGITAXM3lQBwCg~4e25d95b8666457c3ec4e826a230920d
Upcoming events on Accolade, Inc.
Past events on Accolade, Inc.
| 26/04/2024 02:00 am | Q4 2024 Earnings Call |
| 26/04/2024 01:33 am | Q4 2024 Earnings Release |
| 13/03/2024 11:05 pm | Barclays Global Healthcare Conference |
| 05/03/2024 06:35 pm | Raymond James Institutional Investors Conference |
| 19/01/2024 01:30 am | Needham Growth Conference |
| 11/01/2024 09:00 pm | JPMorgan Healthcare Conference |
| 09/01/2024 03:00 am | Q3 2024 Earnings Call |
| 09/01/2024 02:33 am | Q3 2024 Earnings Release |
| 29/11/2023 08:30 pm | Piper Sandler Healthcare Conference |
| 15/11/2023 10:30 pm | Stephens Investment Conference |
| 05/10/2023 02:00 am | Q2 2024 Earnings Call |
| 05/10/2023 01:35 am | Q2 2024 Earnings Release |
| 12/09/2023 11:05 pm | Morgan Stanley Global Healthcare Conference |
| 08/09/2023 05:30 pm | Wells Fargo Healthcare Conference |
| 08/08/2023 07:30 pm | Annual General Meeting |
| 30/06/2023 02:00 am | Q1 2024 Earnings Call |
| 30/06/2023 01:33 am | Q1 2024 Earnings Release |
| 06/06/2023 09:00 pm | Stifel Cross Sector Insight Conference |
| 10/05/2023 04:10 am | Bank of America Healthcare Conference |
| 09/05/2023 01:30 am | Investor Day |
Annual results
| Fiscal Period | February | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 133 | 170 168 1.6% | 310 308 0.66% | 363 364 -0.11% | 414 413 0.2% | 491 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -26,9 -29,1 7.4% | -42,4 -49,6 14.49% | -36,5 -38,1 4.07% | -7,49 -7,94 5.67% | 16,2 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -46,8 -42,1 -11.06% | -126 -116 -8.74% | -464 -417 -11.04% | -114 -116 1.67% | -97,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -50,6 -48,9 -3.53% | -129 -125 -3.11% | -463 -429 -7.92% | -98,6 -98,0 -0.57% | -91,4 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -50,7 -49,9 -1.54% | -123 -117 -5.15% | -460 -460 0.07% | -99,8 -99,7 -0.14% | -93,8 |
|
EPS USD | Released Forecast Spread | -9,13 | -1,72 -1,89 9.1% | -1,93 -1,76 -9.56% | -6,45 -6,49 0.66% | -1,33 -1,32 -0.69% | -1,24 |
| Announcement Date | 16/06/20 | 05/05/21 | 28/04/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
| Fiscal Period | February | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 93,8 91,6 2.38% | 85,5 82,0 4.34% | 87,6 82,9 5.77% | 90,9 87,5 3.9% | 99,0 99,4 -0.42% | 93,2 90,3 3.28% | 96,9 94,1 2.95% | 99,4 96,2 3.3% | 125 124 0.74% | 105 | 113 | 117 | 155 | 124 |
|
EBITDA Million USD | Released Forecast Spread | 1,82 -5,42 133.52% | -15,4 -20,2 23.84% | -13,7 -18,2 24.59% | -10,2 -11,9 13.83% | 2,83 1,26 125.15% | -12,6 -16,4 23.38% | -8,76 -12,3 28.74% | -4,63 -6,09 24.05% | 18,5 18,1 2.21% | -9,22 | -5,79 | 1,45 | 30,7 | -5,70 |
|
EBIT Million USD | Released Forecast Spread | -29,8 -25,5 -16.8% | -346 -45,1 -667.7% | -45,9 -48,7 5.65% | -40,4 -41,5 2.73% | -31,2 -27,8 -12.11% | -39,6 -44,2 10.44% | -35,2 -39,9 11.68% | -31,7 -33,1 4.25% | -7,90 -9,44 16.32% | -37,5 | -35,1 | -27,2 | 1,50 | -35,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,7 -35,4 13.31% | -347 -50,5 -586.51% | -46,3 -49,0 5.51% | -39,8 -41,6 4.29% | -30,5 -28,1 -8.53% | -38,3 -43,8 12.5% | -32,7 -37,7 13.25% | -20,7 -31,3 33.73% | -6,78 -5,63 -20.35% | -35,8 | -33,2 | -25,2 | 1,93 | -35,4 |
|
Net income Million USD | Released Forecast Spread | -34,6 -28,2 -22.36% | -343 -54,5 -529.14% | -46,5 -50,9 8.53% | -39,9 -44,0 9.34% | -30,4 -29,4 -3.54% | -38,4 -45,3 15.25% | -32,8 -39,7 17.26% | -21,1 -32,2 34.51% | -7,51 -6,46 -16.28% | -36,8 | -34,2 | -25,9 | 1,74 | -36,1 |
|
EPS USD | Released Forecast Spread | -0,51 -0,39 -31.69% | -4,92 -0,74 -561.14% | -0,66 -0,72 8.24% | -0,56 -0,62 9.92% | -0,42 -0,42 -0.93% | -0,52 -0,61 15.4% | -0,43 -0,53 19.25% | -0,28 -0,43 35.14% | -0,10 -0,10 -1.01% | -0,48 | -0,44 | -0,34 | 0,02 | -0,45 |
| Announcement Date | 28/04/22 | 30/06/22 | 06/10/22 | 09/01/23 | 27/04/23 | 29/06/23 | 04/10/23 | 08/01/24 | 25/04/24 | - | - | - | - | - |
More events
Past sector events for Accolade, Inc.
| Today | DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 05:00 pm | HCA HEALTHCARE, INC.: Q1 2024 Earnings Release |
| 26/04/2024 04:58 pm | PT MEDIKALOKA HERMINA TBK: Q1 2024 Earnings Release |
| 26/04/2024 11:15 am | MEDICOVER AB: Q1 2024 Earnings Release |
| 26/04/2024 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q1 2024 Earnings Release |
| 26/04/2024 01:33 am | ACCOLADE, INC.: Q4 2024 Earnings Release |
| 25/04/2024 04:28 pm | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
| 25/04/2024 06:39 am | BUMRUNGRAD HOSPITAL: Q1 2024 Earnings Release |
| 25/04/2024 | MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 01:46 am | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACCD Stock
- Calendar Accolade, Inc.
